Cargando…

A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a tertiary care hospital in Southern Thailand

OBJECTIVE: To develop a nomogram for predicting 3-year overall survival (OS) and outcomes of surgically staged patients with uterine carcinosarcomas (UCS). METHODS: This retrospective study analyzed the clinicopathological characteristics, treatment data, and oncological outcomes of 69 patients diag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nanthamongkolkul, Kulisara, Taweerat, Pacharadol, Jiamset, Ingporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Obstetrics and Gynecology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191766/ https://www.ncbi.nlm.nih.gov/pubmed/37078117 http://dx.doi.org/10.5468/ogs.22262

Ejemplares similares

Longer waiting times for early stage cervical cancer patients undergoing radical hysterectomy are associated with diminished long-term overall survival
por: Nanthamongkolkul, Kulisara, et al.
Publicado: (2015)

Nomograms to predict overall survival for patients with endometrial carcinosarcoma
por: Iavazzo, Christos, et al.
Publicado: (2023)

Secondary Erythrocytosis Associated with Uterine Myoma Is Rare but Should Be of Concern
por: Thiangphak, Ekasak, et al.
Publicado: (2023)

Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer
por: Jiamset, Ingporn, et al.
Publicado: (2016)

Clinical Nomograms for Predicting the Overall Survival and Cancer-specific Survival of patients with Ovarian Carcinosarcoma patients after Primary Surgery
por: Ren, Fang, et al.
Publicado: (2021)

Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery
por: Gao, Linzhi, et al.
Publicado: (2021)

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
por: Gracia, Myriam, et al.
Publicado: (2023)

Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer
por: Hanprasertpong, Jitti, et al.
Publicado: (2017)

The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma
por: Park, Hae Jin, et al.
Publicado: (2011)

Establishment and validation of a novel nomogram for survival prediction of ovarian carcinosarcoma
por: Liu, Yi, et al.
Publicado: (2022)

Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma
por: Cory, Lori, et al.
Publicado: (2022)

Trends of uterine carcinosarcoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Fear of cancer recurrence and its predictors among cervical cancer survivors
por: Hanprasertpong, Jitti, et al.
Publicado: (2017)

Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience
por: Nizam, Aaron, et al.
Publicado: (2019)

Uterine Carcinosarcoma in a Patient with Didelphys Uterus
por: Iavazzo, C., et al.
Publicado: (2013)

Role of TGF-β signaling in uterine carcinosarcoma
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2015)

Identification of distinct molecular subtypes of uterine carcinosarcoma
por: An, Yang, et al.
Publicado: (2017)

Targeting the TGFβ pathway in uterine carcinosarcoma
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2020)

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
por: Sertier, Anne-Sophie, et al.
Publicado: (2023)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
por: Lodetti, Giorgia, et al.
Publicado: (2023)

The prognostic significance of the heterologous component in uterine carcinosarcomas
por: Can, Behzat, et al.
Publicado: (2023)

Uterine carcinosarcoma: A 10-year single institution experience
por: Terblanche, Leana, et al.
Publicado: (2022)

Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma
por: Yoon, Gun, et al.
Publicado: (2011)

Trends in incidence of uterine cancer in Songkhla, Southern Thailand
por: Saeaib, Nungrutai, et al.
Publicado: (2018)

Uterine carcinosarcomas: 8-year single center experience of 25 cases
por: Dave, Kalpana S., et al.
Publicado: (2011)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Carcinosarcoma of the uterine cervix arising from Müllerian ducts
por: Kim, Myounghwan, et al.
Publicado: (2015)

Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy
por: Tan, Zhen, et al.
Publicado: (2017)

Brain Metastasis in a Young Patient with Uterine Carcinosarcoma
por: Katiyar, Vatsala, et al.
Publicado: (2019)

Clinical utility of CA-125 in the management of uterine carcinosarcoma
por: Matsuo, Koji, et al.
Publicado: (2018)

In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas
por: McConechy, Melissa K, et al.
Publicado: (2015)

Uterine Carcinosarcoma: A Case Report and Literature Review
por: Kord, Ali, et al.
Publicado: (2020)

The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
por: Moukarzel, Lea A., et al.
Publicado: (2021)

Prognostic value of the TCGA molecular classification in uterine carcinosarcoma
por: Travaglino, Antonio, et al.
Publicado: (2021)

Clostridium and Bacteroides bacteremia as initial presentation of uterine carcinosarcoma
por: Imo, Chinonye S., et al.
Publicado: (2022)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers
por: Bellone, Stefania, et al.
Publicado: (2023)

Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study
por: Kim, Se Ik, et al.
Publicado: (2022)

A novel nomogram to predict the overall survival in esthesinoeroblastoma
por: Jiang, Lijie, et al.
Publicado: (2020)

Adjuvant Treatment Modalities, Prognostic Predictors and Outcomes of Uterine Carcinosarcomas
por: Gungorduk, Kemal, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s2mhkuikn84v2uk0ppoom0ngbp